Sangeeta N. Bhatia, Director of Vertex Pharmaceuticals VRTX, has filed 0 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $267.7K. The latest trade was on 05/04.

SB

SB

Sangeeta N. Bhatia

Director

Company

Vertex Pharmaceuticals VRTX

First filing

23/05/03

Trades

23 trades

Buys / sales

0 / 15

12-month net buying

−$267.7K

Last trade

05/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	05/04	05/05	318 sh	$423.73	$134,746.14	−6.1%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	02/13	02/18	266 sh	$500.00	$133,000	−5.8%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/08/27	25/08/29	266 sh	$386.69	$102,859.54	−5.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/05/02	25/05/05	400 sh	$505.86	$202,344	−7.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/08/30	24/09/04	646 sh	$500.00	$323,000	−12.7%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/08/08	24/08/12	1,292 sh	$466.29	$602,446.68	−22.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/05/02	24/05/03	467 sh	$402.95	$188,177.65	−9.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/10/17	23/10/19	243 sh	$375.00	$91,125	−5.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/10/06	23/10/11	242 sh	$360.00	$87,120	−5.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/08/09	23/08/11	242 sh	$345.51	$83,613.42	−5.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/05/02	23/05/03	580 sh5 trades	$348.28avg.	$202,003.8	−11.1%